Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
25.6M
-
Shares change
-
-247K
-
Total reported value, excl. options
-
$173M
-
Value change
-
-$1.67M
-
Number of buys
-
32
-
Number of sells
-
-7
-
Price
-
$6.76
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q4 2021
51 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q4 2021.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.6M shares
of 60.7M outstanding shares and own 42.15% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.77M shares), Sands Capital Ventures, LLC (3.42M shares), BlackRock Inc. (3.11M shares), Deep Track Capital, LP (1.93M shares), Rock Springs Capital Management LP (1.57M shares), Laurion Capital Management LP (657K shares), JANUS HENDERSON GROUP PLC (627K shares), FRANKLIN RESOURCES INC (602K shares), VANGUARD GROUP INC (555K shares), and GUARDIAN POINT CAPITAL, LP (500K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.